Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
PUT
Crocs
CROX
$5.85B
| $51.9M | 0.01% |
474,000
+251,400
| +113% | +$29.3M |
|
1227
PUT
Tenet Healthcare
THC
$22.6B
| $51.9M | 0.01% |
411,200
-337,500
| -45% | -$50.2M |
|
1228
JD.com
JD
$39.7B
| $51.9M | 0.01% |
1,496,298
+848,814
| +131% | +$32.9M |
|
1229
Rocket Pharmaceuticals
RCKT
$385M
| $51.8M | 0.01% |
4,122,824
+1,974,731
| +92% | +$29.7M |
|
1230
PUT
Viking Therapeutics
VKTX
$3.95B
| $51.8M | 0.01% |
1,286,500
-6,600
| -0.5% | -$376K |
|
|
EA
1231
CALL
DELISTED
Electronic Arts
EA
| $51.6M | 0.01% |
353,000
-92,500
| -21% | -$14.2M |
|
1232
Elevance Health
ELV
$86.9B
| $51.6M | 0.01% |
139,934
+56,744
| +68% | +$23.7M |
|
1233
PUT
CleanSpark
CLSK
$3.08B
| $51.6M | 0.01% |
5,600,800
+756,200
| +16% | +$9.14M |
|
1234
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $51.5M | 0.01% |
389,900
-157,400
| -29% | -$22.1M |
|
1235
CNX Resources
CNX
$5.38B
| $51.5M | 0.01% |
1,405,517
+68,856
| +5% | +$2.54M |
|
1236
CALL
Wayfair
W
$13.9B
| $51.5M | 0.01% |
1,162,700
-312,700
| -21% | -$14.7M |
|
1237
Las Vegas Sands
LVS
$30.5B
| $51.5M | 0.01% |
1,002,563
-562,477
| -36% | -$29.2M |
|
1238
CALL
iShares MSCI Canada ETF
EWC
$6.6B
| $51.4M | 0.01% |
1,275,700
-600
| -0% | -$25K |
|
1239
CALL
Prudential Financial
PRU
$41.8B
| $51.4M | 0.01% |
433,300
-76,700
| -15% | -$9.47M |
|
1240
PUT
Lamb Weston
LW
$7.38B
| $51.3M | 0.01% |
768,300
-4,800
| -0.6% | -$358K |
|
1241
Hershey
HSY
$37.5B
| $51.3M | 0.01% |
302,672
+43,828
| +17% | +$7.86M |
|
1242
CALL
Toast
TOST
$21.2B
| $51.2M | 0.01% |
1,404,800
+15,900
| +1% | +$559K |
|
1243
L3Harris
LHX
$49.7B
| $51.2M | 0.01% |
243,458
-20,425
| -8% | -$4.9M |
|
1244
Beam Therapeutics
BEAM
$3.07B
| $51.1M | 0.01% |
2,062,246
+566,051
| +38% | +$14.4M |
|
1245
PUT
Colgate-Palmolive
CL
$72.6B
| $51.1M | 0.01% |
562,400
+7,900
| +1% | +$754K |
|
1246
iShares MSCI Taiwan ETF
EWT
$11.2B
| $51M | 0.01% |
985,044
+851,743
| +639% | +$46.2M |
|
1247
F5
FFIV
$21.8B
| $50.9M | 0.01% |
202,443
-403,877
| -67% | -$96.6M |
|
|
1248
CALL
Crocs
CROX
$5.85B
| $50.9M | 0.01% |
464,500
+23,200
| +5% | +$2.7M |
|
1249
CALL
American Electric Power
AEP
$65.8B
| $50.8M | 0.01% |
550,400
-125,400
| -19% | -$12.1M |
|
1250
Nu Holdings
NU
$70.4B
| $50.7M | 0.01% |
4,895,236
+4,015,886
| +457% | +$53.4M |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.